SCHEMBL533750

SCHEMBL533750

CC(C)(Cc1ccc(Br)c(C(N)(Cc2ccc(-c3ccccc3)nn2)S(=O)(=O)c2cccnc2)n1)OC(=O)NC(C(=O)O)C(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.31
USP8 P40818 1/20 0.31
ADAM17 P78536 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3458635 0.88 PTGER2 (0.33)
SCHEMBL534420 0.82 ADAM17 (0.37) USP2USP8ADAM17
SCHEMBL11021873 0.82 PTGER2 (0.40)
SCHEMBL533752 0.79
SCHEMBL534322 0.79 PTGER2 (0.41)
SCHEMBL533751 0.78
SCHEMBL533797 0.77 PTGER2 (0.36) ADAM17
SCHEMBL3458643 0.77 PTGER2 (0.32)
SCHEMBL3458639 0.76
SCHEMBL533426 0.71 PTGER2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8648097-B2 Pyridylaminoacetic acid compound UBE INDUSTRIES, LTD. (JP) 2014-02-11 US disclosed
EP-2415763-A1 PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING GLAUCOMA Ube Industries, Ltd. (JP) 2012-02-08 EP disclosed